NFKB1 and esophageal squamous cell carcinoma: The NF-κB signaling pathway is constitutively activated in ESCC cell lines and RNA interference targeting at p65 increases the sensitivity of ESCC cell lines to 5-fluorouracil chemotherapy [71].